Susan Hasty, Publisher
Table of Contents . . . March 21st, 2006
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Disease Prevention Week | Other Publications
Drug Development - Arixtra shown to reduce risk of venous thromboembolism in acutely ill patients
Health Promotion Board, Singapore - Data advance knowledge in SARS research
Ingen Technologies, Inc. - Ingen Technologies prepares for marketing release of Secure Balance
International Life Sciences Institute Europe - Overweight and obesity prevention program for youth appear affective
3M - 3M increases dividend 9.5%
Aarhus University Hospital - Tryptase- and chymase-related gene clusters identified in human mast cells
Acacia Research Corp. - Acacia Research reports revenues of $8.2M
Acacia Research Corp. - Additional CRDA with the U.S. Air Force announced by CombiMatrix
Accentia Biopharmaceuticals, Inc. - Biovest submits amendment request to U.S. FDA for BiovaxID personalized anticancer vaccine
Advaxis, Inc. - Advaxis' listeria cancer vaccine receives regulatory approval for phase I/II testing
Alba Therapeutics Corp. - Alba Therapeutics receives new federal, state grant awards for work on zonulin pathway
Allergy Therapeutics plc - Allergy Therapeutics commences sublingual allergy vaccine trial
American Academy of Neurology - Few stroke patients get to hospital in time for treatment
American College of Foot & Ankle Surgeons - Better athletic training can curb cheerleader injuries
American Medical Systems Holdings, Inc. - American Medical Systems announces 100,000th implant of male incontinence device
Anodyne Medical Device, Inc. - Compass Group, Hollywood Capital form Anodyne Medical Device to buy support surface makers
Antigenics, Inc. - Antigenics reports loss of $0.39 per share
Arpida, Ltd. - Oral iclaprim shown to achieve results comparable to intravenous administration
Asahi University, Mizuho - Endothelium-independent vasorelaxation is induced by protamine sulfate via NO synthase pathway
Aspreva Pharmaceuticals Corp. - Aspreva Pharmaceuticals reports earnings of $0.68 per share
Ataturk Training & Research Hospital, Izmir - Restoration of thyroid function improves quality of life and psychological symptoms
Atherotech, Inc. - Atherotech names Michael Mullen chief financial officer
Axcan Pharma, Inc. - Itopride does not meet primary endpoint in phase III trial
Barr Pharmaceuticals, Inc. - Barr summary judgment affirmed by federal court in DDAVP patent challenge
Barrier Therapeutics, Inc. - Vusion ointment for diaper dermatitis complicated by candidiasis approved by U.S. FDA
Baylor College of Medicine, Houston - Normal adipogenesis and lower fatty liver risk are observed in mice lacking ADFP
Baylor University, Waco - Characterization of aggressive behavior influences the success of pharmacological treatment
Best Practices, LLC - Generating value from strategic alliances and partnerships reviewed in study
BioForce Nanosciences, Inc. - Bioforce developing method for detecting foodborne pathogens
BioLife Solutions, Inc. - BioLife study examines Calpains and their influence on overall cell survival
Biocompatibles International plc - Start of trial to evaluate drug eluting bead in lung cancer announced
Biogen Idec, Inc. - Melanoma angiogenesis models display a significant response to PEGylated interferon
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.